Company: SCLXW
Filing Date: 2025-01-17
Form Type: 10-Q
Source: 0000950170-25-006755
Chunk: 43

Company: Scilex Holding Co
Filing Date: 2025-01-17
Form: 10-Q
Item: Item 1
Chunk 43
---
    (92,931
    )

    Adjustments to reconcile net loss to net cash proceeds from (used for) operating activities:

    Depreciation and amortization
     
    3,042

    3,112

    Amortization of debt issuance costs and debt discount
     
    94

    34

    Non-cash operating lease cost
     
    547

    330

    Stock-based compensation
     
    10,884

    10,813

    (Gain) loss on derivative liability
     
    (2,367
    )

    1,090

    Allocated expenses for warrant issuance cost
     
    2,526

    —

    Change in fair value of debt and liability instruments
     
    11,961

    4,197

    Allowances for expected credit losses
     
    1,186

    —

    Other
     
    392

    731

    Changes in operating assets and liabilities:

    Accounts receivables, net
     
    1,831

    4,808

    Inventory
     
    1,496

    (2,565
    )

    Prepaid expenses and other
     
    (2,857
    )

    1,072

    Other long-term assets
     
    (30
    )

    804

    Accounts payable
     
    2,266

    11,486

    Accrued payroll
     
    (1,706
    )

    1,779

    Accrued expenses
     
    2,463

    5,525

    Accrued rebates and fees
     
    52,051

    34,907

    Other liabilities
     
    (593
    )

    (519
    )

    Other long-term liabilities
     
    (24
    )

    10

    Net cash proceeds from (used for) operating activities
     
    16,815

    (15,317
    )

    Investing activities

    Acquisition consideration paid in cash for Romeg intangible asset acquisition
     
    (450
    )

    (134
    )

    Purchase of equity securities
     
    (2,000
    )

    —

    Purchase of convertible promissory note from Denali
     
    (30